首页> 外国专利> Biaril espiroaminooxazolina analogues and espiroaminodiazolina modulators alfa2c adrenergic Receptors, Pharmaceutical compositions containing same and Use thereof in allergic rhinitis, Heart Disorders and other diseases

Biaril espiroaminooxazolina analogues and espiroaminodiazolina modulators alfa2c adrenergic Receptors, Pharmaceutical compositions containing same and Use thereof in allergic rhinitis, Heart Disorders and other diseases

机译:Biaril espiroaminooxazolina类似物和espiroaminodiazolina调节剂alfa2c肾上腺素能受体,包含它们的药物组合物及其在变应性鼻炎,心脏疾病和其他疾病中的用途

摘要

Claim 1: a compound represented by the formula (1) or a pharmaceutically acceptable Salt thereof, where J1, J2, J3 and J4 are independently - N -, N - (o) -, - C (R2) - X - C (r6) (r6) -, - N (r6) -, - O -, - S - W is N (R15) -, - or - or - S - Z is independently selected from the Group; Consisting of H, Oh, Halo, - CN, - NO2, - S (o) - PR7, nr7r7 '- [c] (RA) (RB) qyr7' - [c] (RA) (RB) yr7 QN (R7) ',- [c] (RA) (RB) qoyr7 ', and' cr7r7 Wut = (CH2), and alkyl groups, alkoxy, alquenilo, alqueniloxi, alquinilo cicloalcoxi, cycloalkyl, aryl, heteroaryl, ariloxi, arylalkyl heteroarilalquilo heterociclilo,,,, and heterociclilalquilo optionally substituted with at least one R5; where -- - IT's a Single or dual link with the condition that when w IS - or - or - S -,The Double bond is present between n and 2 position, and when W is N (R15), the double bond is present between n and W and the position 2 or 2 position, but not 2 contiguous Double Bonds can form a Ring; r1 is selected from the group consisting cicloalquenilo, cycloalkyl, aryl, I Terociclilo, heterociclenilo and heteroaryl,Each of which is optionally substituted with at least one R12; R2 is absent or is independently selected from the group consisting of H, Halo, - CN, - NO2, - Oh, - S (o) - PR7, nr7r7 '- [c] (RA) (RB) qyr7', - [c] (RA) (RB) QN (R7) yr7 '- [c] (RA) (RB) QN (R7) CN, - [c] (RA) (RB) qo yr7') and - (CH2) = C Wut R7r7 'groups, and alkyl, alkoxy, alquenilo, alqueniloxi, alquinilo, cycloalkyl, aryl, cicloalcoxi,Ariloxi, arylalkyl, heteroaryl, heteroarilalquilo, heterociclilo and heterociclilalquilo substituted with at least one R5, and is selected from the group consisting of a Link, - C (= o) -, - C (= o) nr7 -, - C (= o) -, - C (= o) n (RC) -, - C (= nr7) -, - C (= nor7) -, - C (= nr7 nr7) -, - C (= nr7o nr7) -, - C (= N - S (- CN), or So2nr7) P - - -And - C (= o) - Where nr7; ra and RB are independently selected from the group consisting of H, alkyl, alkoxy, and Halo, and RC is H or alkyl; R3 is independently selected from the group consisting of H, Oh, Halo, - CN, - NO2, or - S (- nr7r7 PR7), 's' pnr7r7 and (OR) (= OR), and alkyl groups, ALCO XI, alquenilo, alqueniloxi, alquinilo, cycloalkyl, aryl, ariloxi arylalkyl cicloalcoxi,,,Heteroaryl, heteroarilalquilo, heterociclilo, and heterociclilalquilo optionally substituted with at least one R5, with the condition that when W is 3, not more than 2 groups can be (= r3 or R4); is independently selected from the group consisting of H, D, - Oh, Halo, - CN, - S (o) - nr7r7 PR7, 'and' pnr7r7 - S (o), and alkyl groups, deuterizado alkyl, alkoxy, alquenilo, alqueniloxi,Alquinilo, cicloalcoxi, cycloalkyl, aryl, heteroaryl, ariloxi, arylalkyl, heteroarilalquilo, heterociclilo, and heterociclilalquilo, optionally substituted with at least one R5; R4 is independently selected from the group consisting of H, D, Halo, - Oh, alkyl and alkyl deuteriz Ado and alkoxy; or R4 R4 'can be taken together to form (= o),With the condition that when M 1, there is no more than 1 Group (= OR); R5 is independently selected from the group consisting of H, Halo, - Oh, - CN, - NO2, nr7r7 's, and (OR) alkyl and alkoxy groups, PR7, alquenilo alqueniloxi,,, alquinilo, cicloalcoxi, cycloalkyl, aryl, ariloxi, arylalkyl, het Eroarilo, heteroarilalquilo, heterociclilo, and heterociclilalquilo,Each of which is optionally substituted with at least one of the Halo Substituent, - Oh, - CN, - NO2, nr7r7 '-, and - S (o) and / or PR7 1 or 2 groups (= OR); R6 is selected from the group consisting of H, Oh, Halo, - CN, - NO2, - S (o) - nr7r7 PR7,' s' (or pnr7r7) -, - C (o) - R10, - C (o) - or10, and groups Alkyl, alkoxy, alquenilo, alqueniloxi, alquinilo, cycloalkyl, aryl, ariloxi, cicloalcoxi,Aralquilo, heteroaryl, heteroarilalquilo, heterociclilo and heterociclilalquilo, each of which is optionally substituted with at least one (preferably 1 to 5, preferably 1 to 3) of Halo substituents, - Oh, - CN, - NO2, nr7r7 '-, and - S (o) and / or PR7 1 or 2 groups (= O) - C (= o R7), or7 - C (= o) - C (= o) - so2r7 nr7r7 ', and' - so2nr7r7; r6 'is selected from the group consisting of H,- S (o) PR7, pnr7r7 's (o) -, - C (o) - R10, or10 - C (o) -, - C (o) - N (R7) R10 groups and alkyl, alkoxy, alquenilo, alqueniloxi, alquinilo, cycloalkyl, aryl, ariloxi arylalkyl cicloalcoxi,,, heteroaryl, heteroarilalquilo heterociclilo, and heterociclilalquilo, each of which is optionally substituted With at least one (preferably 1 to 5More preferably 1 to 3) of the Halo Substituent groups, - Oh, - CN, - NO2, nr7r7 '-, and - S (o) and / or PR7 1 or 2 (= o) - C (= o) R7, - C (= o) - C (= or7, or nr7r7'), so2r7 - and - so2nr7r7 '; or' R6 and R6 can be taken together to form (= OR); R7 is independently selected from the group consisting of H And alkyl groups, alquenilo, alquinilo, cycloalkyl, cicloalquilalquilo, cicloclenilo,Ciclociclenilalquilo, arylalkyl, heterociclilo, aryl, heteroaryl heterociclenilalquilo heterociclenilo heterociclilalquilo,,,, and heteroarilalquilo, each of which is optionally substituted by one or more times with R12; R7 is independently selected from the group consisting of H and alkyl groups, alquenilo, alquinilo, cycloalkyl, cicloalquilalquilo, cicloclenilo,Cicloclenilalquilo, arylalkyl, heterociclilo, aryl, heteroaryl heterociclenilalquilo heterociclenilo heterociclilalquilo,,,, and heteroarilalquilo, each of which is optionally substituted by one or more times with R12; or when a variable is nr7r7) -, - C (o) - so2nr7r7 nr7r7 'Or',R6 and R7 'in conjunction with the nitrogen Atom to which together form a Ring heterociclilo Regardless, heterociclenilo or heteroaryl 3 to 8 members, which also has the Atom n, 1 or 2 additional heteroatoms independently selected from the group consisting of o, n (R9) -, - N and SSuch Rings which are optionally substituted with 1 to 5 remains R12 independently selected and / or 1 or 2 groups (= o), or (b) when a variable is - (CH2) = cr7r7 Wut, R7 and R7 'in conjunction with the carbon Atom to which they are United to form a cycloalkyl Ring Regardless, Ci Cloalquenilo, aryl or heteroaryl, heterociclilo, heterociclenilo 3 to 8 members,Where such Rings heterociclilo heterociclenilo heteroaryl, or have 1 to 3 heteroatoms are independently selected from the group consisting of o, N, N - (R9) - and S, where the Rings are optionally substituted with 1 to 5 remains R12 independently selected and / or 1 or 2 (= o) groups; R9 is independently selected from the group consisting of H, - C (o) - R10- C (o) - or10, and - S (o) P - R10 and alkyl groups, alquenilo, alquinilo, cycloalkyl, aryl, heteroaryl heteroarilalquilo arylalkyl,, and, each of which is optionally substituted with at least one Halo Substituent, - Oh, - CN, - NO2 - N (R11 - S) 2 and (OR) PR11 and / or 1 or 2 groups (= OR) and R10 is Independently selected from the group consisting of H, alkyl groups, alquenilo, alquinilo,Arylalkyl, cycloalkyl, aryl, heteroaryl, and heteroarilalquilo, each of which is optionally substituted with at least one of the Halo Substituent, - Oh, - CN, - NO2 - N (R11) 2 and (OR) - S, PR11 and / or 1 or 2 groups (= o); R11 is an independently Selected the Group consis I in H and alkyl groups, alkoxy, alquenilo, alqueniloxi, alquinilo, cycloalkyl, cicloalcoxi,Ariloxi, aryl, heteroaryl heteroarilalquilo heterociclilo arylalkyl,,,, and heterociclilalquilo, each of which is optionally substituted with at least one Substituent selected from the group consisting of Halo, - Oh, - CN, - NO2 - N (R11 '- S) 2 and (OR) PR11' and / or 1 or 2 groups (= OR) R11 '; Is independently selected from the group consisting of H, alkyl, alkoxy, alquenilo,Alqueniloxi, alquinilo cicloalcoxi, cycloalkyl, aryl, heteroaryl, ariloxi, arylalkyl heteroarilalquilo heterociclilo,,,, and heterociclilalquilo; R12 is independently selected from the group consisting of H, Halo, - Oh, - CN, - NO2 - N (R11) 2, - C (o) - N - (or14, R14) - C (o) - R14, - N (R14) - C (o) - R1 2 4, - C (o) - n 2 - N (R11) (R14) - S (o) 2 - (R11, - s or - N (R11) 2 -) 2 and (OR) PR11 and / or 1 or 2 groups (= o),Alkyl and alkoxy groups,, alquenilo, alqueniloxi, alquinilo, cycloalkyl, cicloalquenilo, cicloalcoxi, aryl, heteroaryl, ariloxi, arylalkyl, heteroariloxi, heteroarilalquilo, heterociclilo, heterociclenilo, heterocicleniloxi, heterociclilalquilo, heteroclenilalquilo, ariialcoxi, heteroarilalco XI, heterocicliialcoxi and heterociclenilalcoxi,Each of which is optionally replaced at least once by a Substituent selected from the group consisting of H, alkyl, Halo, haloalquilo, - Oh, ariloxi alkoxy optionally substituted, optionally substituted, optionally substituted cicloalcoxi, heteroariloxi option Finally heterocicleniloxi substituted, optionally substituted, - CN, - NO2 - N (R11) 2And - S (o) PR11 and / or 1 or 2 groups (= o), where such ariloxi alkoxy optionally substituted, optionally substituted, cicloalcoxi, heteroariloxi optionally substituted, and when they are heterocicleniloxi replaced one or more times with R11, R14 is independently h, alkyl, or aryl; R 15 is absent or is independently selected from the group consisting of H, - C (o) - R10Or10 - C (o) -, - C (= o) - N (R7) (R7), and - S (o) P - R10 - SO2 - nr7r7 'and alkyl groups, alkoxy, alquenilo, alqueniloxi, alquinilo cicloalcoxi, cycloalkyl, aryl, heteroaryl ariloxi arylalkyl,,,, heteroarilalquilo heterociclilo heterociclilalquilo,, and, each of which is optionally substituted C On at least one of Halo, - Oh, - CN, - NO2 - nr7r7 ',And - S (o) and / or PR7 1 or 2 Substituent groups (= o) - C (= o) R7, - C (= o) or7, - C (= o) - so2r7 nr7r7 ', and' - so2nr7r7; Q is independently an integer from 0 to 10; n is independently an integer of 0 - 2; M is an integer of 1 - 3 independently; whether p is an integer of 0 - 2, and W is an integer of 0 - 3.
机译:权利要求1:由式(1)表示的化合物或其药学上可接受的盐,其中J 1,J 2,J 3和J 4独立地为-N-,N-(o)-,-C(R2)-X-C( r6)(r6)-,-N(r6)-,-O-,-S-W为N(R15)-,-或-或-S-Z独立地选自组;由H,Oh,Halo,-CN,-NO2,-S(o)-PR7,nr7r7'-[c](RA)(RB)qyr7'-[c](RA)(RB)yr7 QN(R7)组成),-[c](RA)(RB)qoyr7'和'cr7r7 Wut =(CH2),以及烷基,烷氧基,alquenilo,alqueniloxi,alquinilo cicloalcoxi,环烷基,芳基,杂芳基,芳基,芳基,杂芳基,杂芳基, 、、和杂亚基喹啉基任选地被至少一个R 5取代;其中--IT是单链路或双链路,其条件是,当w IS-或-或-S-时,n键和2位之间存在双键,而当W为N(R15)时,存在双键在n和W之间以及位置2或2的位置之间,但2个连续的双键不能形成环; r1选自环氯喹啉基,环烷基,芳基,叔萜基,杂烯基和杂芳基,其中的每一个任选地被至少一个R12取代; R2不存在或独立地选自H,卤素,-CN,-NO 2,-哦,-S(o)-PR 7,nr7r 7'-[c](RA)(RB)qyr7',-[ c](RA)(RB)QN(R7)yr7'-[c](RA)(RB)QN(R7)CN,-[c](RA)(RB)qo yr7')和-(CH2)= C Wut R7r7'基团,以及被至少一个R 5取代的烷基,烷氧基,alquenilo,alqueniloxi,alquinilo,环烷基,芳基,cicloalcoxi,Ari​​loxi,芳基烷基,杂芳基,杂芳基芳基,杂环基和杂环基链接-C(= o)-,-C(= o)nr7-,-C(= o)-,-C(= o)n(RC)-,-C(= nr7)-,-C( = nor7)-,-C(= nr7 nr7)-,-C(= nr7o nr7)-,-C(= N-S(-CN)或So2nr7)P---和-C(= o)-其中nr7; ra和RB独立地选自H,烷基,烷氧基和Halo,且RC为H或烷基; R 3独立地选自H,Oh,卤素,-CN,-NO 2或-S(-nr7r7 PR7),'s'pnr7r7和(OR)(= OR),以及烷基ALCO XI, Alquenilo,alqueniloxi,alquinilo,环烷基,芳基,芳基氧基芳基烷基cicloalcoxi,杂芳基,杂芳基,杂环基和杂环基,任选地被至少一个R5取代,条件是当W为3时,不超过2个基团r3或R4);选自H,D,-Oh,卤素,-CN,-S(o)-nr7r7 PR7,'和'pnr7r7-S(o)和烷基,氘代烷基,烷基,烷氧基,alquenilo,任选地被至少一个R 5取代的alqueniloxi,Alquinilo,cicloalcoxi,环烷基,芳基,杂芳基,ariloxi,芳烷基,杂芳基,杂基和杂基。 R4独立地选自H,D,卤素,-Oh,烷基和烷基氘代烷基Ado和烷氧基;或R4 R4'可以合起来形成(= o),条件是当M> 1时,不超过1个基团(= OR); R 5独立地选自H,卤素,-Oh,-CN,-NO 2,nr 7r7以及(OR)烷基和烷氧基,PR 7,alquenilo alqueniloxi 、、 alquinilo,cicloalcoxi,环烷基,芳基,芳基,芳基烷基,杂芳基,杂芳基,杂芳基和杂芳基,其中的每一个任选地被至少一个卤素取代基取代,-取代基--Oh--CN,-NO2,nr7r7'-和-S(o)和 /或PR7 1或2组(= OR); R6选自H,Oh,Halo,-CN,-NO2,-S(o)-nr7r7 PR7,'s'(或pnr7r7)-,-C(o)-R10,-C(o )-或10,以及基团烷基,烷氧基,alquenilo,alqueniloxi,alquinilo,环烷基,芳基,ariloxi,cicloalcoxi,Aralquilo,杂芳基,杂芳基alquilo,heterociclilo和heterociclilalquilo,它们各自可选地至少被至少一个(优选1至5,最好是1至3个)的卤素取代基-Oh,-CN,-NO2,nr7r7'-和-S(o)和// PR7 1或2个基团(= O)-C(= o R7)或7 -C(= o)-C(= o)-so2r7 nr7r7','-so2nr7r7; r 6'选自H,-S(o)PR7,pnr7r7's(o)-,-C(o)-R10,或10-C(o)-,-C(o)-N( R7)R10基团和烷基,烷氧基,alquenilo,alqueniloxi,alquinilo,环烷基,芳基,ariloxi芳基烷基cicloalcoxi,杂芳基,杂芳基杂环基和杂环基,各自任选地被至少一个(优选1至5更优选1取代)到3)的卤素取代基组-哦,-CN,-NO2,nr7r7'-和-S(o)和 /或PR7 1或2(= o)-C(= o)R7,-C (= o)-C(= or7或nr7r7'),so2r7-和-so2nr7r7';或者R6和R6可以一起形成(= OR);或者R 7独立地选自H和烷基,烷基,alquenilo,alquinilo,环烷基,cicloalquilalquilo,cicloclenilo,Ciclociclenilalquilo,芳基烷基,杂环基,芳基,杂芳基杂杂环基杂芳基,杂环基杂芳基,,和杂芳基基,各自任选地被R 12取代一次或多次; R 7独立地选自H和烷基,其中Alquenilo,alquinilo,环烷基,cicloalquilalquilo,cicloclenilo,Cicloclenilalquilo,芳基烷基,杂环基,芳基,杂芳基杂杂环基杂芳基,杂环烯基杂芳基各被、、和,被杂芳基杂芳基取代,使用R12一次或多次;或当变量为nr7r7)-,-C(o)-so2nr7r7 nr7r7'Or',R6和R7'与氮原子一起形成环杂环,无论如何,杂环烯基或杂芳基为3至8个成员,具有原子n,1或2个独立的杂原子,分别选自o,n(R9)-,-N和SSuch环,它们可选地被1-5个取代,剩下的R12独立地选自R12和//或1或2个基团(= o),或(b)当变量为-(CH2)= cr7r7 Wut,R7和R7'与它们所连接的碳原子一起形成环烷基环时,无论是Ci Cloalquenilo,芳基还是杂芳基,杂环基,杂环烯基3至8个成员,其中这样的环杂环杂烯基杂芳基或具有1至3个杂原子独立地选自o,N,N-(R9)-和S,其中环任选地被1取代至5个仍独立选择的R12和1或2(= o)组; R9独立地选自H,-C(o)-R10-C(o)-或O10和-S(o)P-R10和烷基,烷基,烷基,环烷基,芳基,杂芳基杂芳基芳基烷基,和,并且各自可选地被至少一个卤素取代基取代-Oh,-CN,-NO2-N(R11-S)2和(OR)PR11和//或1或2个基团(= OR) R10独立地选自H,烷基,alquenilo,alquinilo,芳烷基,环烷基,芳基,杂芳基和杂芳基铝基,它们各自任选地被至少一个卤代取代基取代,-Oh,-CN ,-NO 2-N(R11)2和(OR)-S,PR11和 /或1或2组(= o); R11是在H和烷基,烷氧基,alquenilo,alqueniloxi,alquinilo,环烷基,cicloalcoxi,Ari​​loxi,芳基,杂芳基杂芳基杂芳基杂芳基烷基芳基烷基中独立地选择的基团I,它们各自任选地被取代为选自Halo,-Oh,-CN,-NO 2 -N(R11'-S)2和(OR)PR11'的至少一种取代基和/或1或2个基团(= OR)R11';选自H,烷基,烷氧基,Alquenilo,Alqueniloxi,Alquinilo cicloalcoxi,环烷基,芳基,杂芳基,ariloxi,芳基烷基,杂芳基,杂芳基,和杂杂基。 R12独立地选自H,卤素,-Oh,-CN,-NO 2 -N(R11)2 --C(o)-N-(or14,R14)-C(o)-R14,- N(R14)-C(o)-R1 2 4,-C(o)-n 2-N(R11)(R14)-S(o)2-(R11,-s或-N(R11)2- )2和(OR)PR11和 /或1或2个基团(= o),烷基和烷氧基,alquenilo,alqueniloxi,alquinilo,环烷基,cicloalquenilo,cicloalcoxi,芳基,杂芳基,ariloxi,芳基烷基,杂芳基,杂芳基,杂香油基,杂香油基,杂香油基,杂香油基,杂香油基,ariialcoxi,杂芳基co XI,杂香油香和杂香油基,其中的每一个任选地被选自由H,烷基,卤代,卤代,卤代,卤代,烷氧基和卤素组成的组的取代基至少一次替代。任选地被取代,任选地被取代,任选地被取代的环氯噻吩,杂芳烃选项最后被杂烯基环被取代,任选地被取代的-CN,-NO 2 -N(R 11)2和-S(o)PR 11和// 1或2个基团(= o),其中这种芳基烷氧基任选取代,任选取代,环氯苯氧基,杂芳基任选取代,并且当它们被R11取代时,R14,R14独立地是h,烷基或芳基; R 15不存在或独立选自H,-C(o)-R10Or10-C(o)-,-C(= o)-N(R7)(R7)和-S(o) P-R 10-SO 2-nr7r7′和烷基,烷氧基,alquenilo,alqueniloxi,alquinilo cicloalcoxi,环烷基,芳基,杂芳基,ariloxi芳烷基、、、杂芳基芳基,杂芳基,杂芳基,杂芳基,以及每个均被至少一个上的C取代的卤素,-哦,-CN,-NO2-nr7r7',和-S(o)和 /或PR7 1或2个取代基(= o)-C(= o)R7,-C(= o)或7 ,-C(= o)-so2r7 nr7r7',和'-so2nr7r7; Q独立地是0到10的整数; n独立地是0-2的整数; M独立地是1-3的整数; p是0到2的整数,W是0到3的整数。

著录项

  • 公开/公告号AR073628A1

    专利类型

  • 公开/公告日2010-11-17

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号AR2009P103840

  • 发明设计人

    申请日2009-10-06

  • 分类号C07D263/58;C07D235/02;C07D401/10;C07D403/10;C07D405/10;C07D409/10;C07D413/10;C07D417/10;C07D405/14;C07D409/14;C07D498/10;A61K31/423;A61K31/424;A61K31/4184;A61K31/4188;A61P11/02;A61P9/04;A61P27/06;A61P25/00;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号